@article{article, title  = {{Adjusting for treatment crossover in the BREAK-3 metastatic melanoma trial for dabrafenib: Preliminary analysis.}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{}},

 year = {{2013}},

 month = {{5}},

 author = {{Latimer N and Abrams KR and Amonkar M and Stapelkamp C and Swann RS}},

 doi = {{10.1200/jco.2013.31.15_suppl.9044}},

 volume = {{31}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{15_suppl}},

 pages = {{9044-9044}},

 note = {{Accessed on 2025/02/14}}}